Monthly Archives: December 2016

Biopharmaceutical News Week # 2016.51

    Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com       Editor’s Note   This is the final edition of Biopharmaceutical NewsWeek of 2016. It has been a great, sometimes challenging and even difficult year for some of us and we, therefore, want to thank all of you for your continuous support. We wish all […]

read more

Biopharmaceutical News Week # 2016.50

  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com     Mergers, Acquisitions and Joint Ventures   Johnson & Johnson withdrew from a potential acquisition of Actelion indicating that it had not been able to reach an agreement that would create adequate value for its shareholders. According to Reuters, Actelion stated that the company is « engagged in […]

read more

Biopharmaceutical News Week # 2016.49

     Biopharmaceutical News Week # 2016.49     Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com       Editor’s Note   We have again encountered limited access to our data base which obliged us to cancel two recent editions of this Newsweek and edit a truncated version of this week issue. Thank you for your […]

read more